首页> 美国卫生研究院文献>Antibiotics >In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug- Carbapenem- and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods
【2h】

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug- Carbapenem- and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods

机译:使用肉汤微冰核验棋和时间杀死方法对多rrug-carbapeNem-和耐菌抗性传导杆菌组合的体外活性的组合和耐菌抗性肺杆菌组合

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Drug-resistant ) infections are a critical global problem, with limited treatment choices. This study aims to determine the in vitro activities of colistin–sitafloxacin combinations against multidrug-, carbapenem- and colistin-resistant (MDR-AB, CRAB, CoR-AB, respectively) clinical isolates from tertiary care hospitals. We used the broth microdilution checkerboard and time-kill methods in this study. Synergy was found using both methods. The colistin–sitafloxacin combination showed synergy in MDR-AB, CRAB, and CoR-AB isolates (3.4%, 3.1%, and 20.9%, respectively). No antagonism was found in any type of drug-resistant isolate. The majority of CoR-AB isolates became susceptible to colistin (95.4%). The time-kill method also showed that this combination could suppress regrowth back to the initial inocula of all representative isolates. Our results demonstrated that the colistin–sitafloxacin combination might be an interesting option for the treatment of drug-resistant . However, further in vivo and clinical studies are required.
机译:耐药性)感染是一个关键的全球问题,治疗选择有限。本研究旨在确定Colistin-sitafloxacin组合对来自第三级护理医院的临床分离株的Molistin-Sitafloxacin组合的体外活性。我们在本研究中使用了肉汤微量钢丝棋盘和时间杀死方法。使用这两种方法都发现了协同作用。 Colistin-Sitafloxacin组合在MDR-AB,Crab和Cor-AB分离株(分别为3.4%,3.1%和20.9%)中表现出协同作用。在任何类型的耐药隔离物中没有发现拮抗作用。大多数Cor-AB分离物变得易受胚胎(95.4%)的影响。时间杀灭方法还表明,这种组合可以抑制回到所有代表性分离株的初始接种物的再生。我们的研究结果表明,Colistin-Sitafloxacin组合可能是治疗耐药性的有趣选择。然而,进一步在体内和临床研究中是必需的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号